EUGENE SANDERS, M.D.
Lincomycin shares many of the pharmacologic, toxicologic, and antibacterial properties of erythromycin. It offers few therapeutic advantages in comparison with erythromycin when the infecting microorganism is susceptible to both drugs. For the present lincomycin is clearly preferred only when the patient is intolerant to erythromycin, the infecting agent is insusceptible to erythromycin, or possibly when lincomycin-susceptible microorganisms are located within bone.
Learn more about subscription options.
Register Now for a free account.
SANDERS E. Lincomycin Versus Erythromycin: A Choice or an Echo. Ann Intern Med. 1969;70:585–590. doi: 10.7326/0003-4819-70-3-585
Download citation file:
Published: Ann Intern Med. 1969;70(3):585-590.
Cardiac Diagnosis and Imaging, Cardiology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only